Carcinogenicity of lipid-lowering drugs.
Pahor
M
M
D000214:Acyl Coenzyme A / Q000037:antagonists & inhibitors; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000494:pharmacology; D008099:Liver / Q000187:drug effects*; D008113:Liver Neoplasms / Q000139:chemically induced*; D008148:Lovastatin / Q000009:adverse effects / Q000494:pharmacology
D000214:Acyl Coenzyme A; D004791:Enzyme Inhibitors; D000960:Hypolipidemic Agents; C008047:3-hydroxy-3-methylglutaryl-coenzyme A; D008148:Lovastatin